精品亚洲成a人片在线观看,国产精品一区二区亚瑟不卡,欧美激情国产,国产在线国偷精品免费看 -99久久超碰中文字幕伊人_人人插人人插人人爽_日韩AV激情在线观看_亚洲愉拍自拍欧美精品

Neurotropic Tyrosine Receptor Kinase (NTRK) is a type of biomarker for cancer therapy and can be found in over 25 different types of cancer. NTRK gene fusions can be detected with a number of biomarker tests including NGS (Next Generation Sequencing). This is the only way to identify people who may be eligible for therapies that target these mutations. OrigiMed has one of the clinical databases with information on gene fusion. OriFusion is a patented technique, in partnership with Bayer, to detect specific gene fusions which allows treatment with targeted therapies such as Entrectinib. Companion Diagnostics (CDx) is a testing panel that screens for hundreds of gene sequences to be compared against known matches, which then allows for other specific targeted therapies to be used.